Cantor Equity Partners IV Appoints Dr. Mukesh Prasad to Board

What Happened

• Cantor Equity Partners IV, Inc. announced on August 25, 2026 the appointment of Dr. Mukesh Prasad as a Class I director. He was also named a member of the Board’s audit committee and compensation committee.
• Dr. Prasad, age 55, is Founder and Co-Managing Partner of Innova Capital Partners (since 2014) and has served as an Otolaryngologist and Associate Professor of Clinical Otolaryngology and Head & Neck Surgery at Weill Cornell Medical College since 2002. He has held prior Cantor Equity Partners directorships (Cantor Equity Partners V since Nov 2025; Cantor Equity Partners II from May 2026 until its July 2026 business combination).
• The Board approved cash compensation of $50,000 per year for Dr. Prasad’s service, payable quarterly. There are no family relationships between Dr. Prasad and any of the Company’s directors or executive officers.

Key Details

• Effective date: August 25, 2026.
• Role: Appointed as Class I director and member of the audit and compensation committees.
• Compensation: $50,000 per year, paid quarterly.
• Relevant background: Founder/Co-Managing Partner of Innova (since 2014); Weill Cornell clinician and associate professor (since 2002); former advisor to U.S. Department of Commerce (2023–Jan 2025); member, Council on Foreign Relations since 2015.

Why It Matters

• A new director with experience in finance, investing and healthcare has been added to the Board and to committees that oversee financial reporting (audit) and pay practices (compensation), which can influence governance and oversight.
• The $50,000 annual board fee is a concrete, modest cash expense for the company and indicates the Board’s approved compensation for this position.
• Dr. Prasad’s prior roles with other Cantor Equity Partners entities suggest continuity and familiarity with the sponsor’s network and governance practices.